Hoffmann-La Roche

Boehringer Ingelheim Pharmaceuticals is a Connecticut-based company that is one of the largest U.S.-based subsidiaries of Boehringer Ingelheim Corporation. Boehringer Ingelheim Pharmaceuticals funds research studies in the areas of urologic disease, benign prostatic hypertrophy, oncology, female sexual health, hypoactive sexual desire disorder, diabetes and general pharmacy. The holding company is one of the world s leading pharmaceutical companies. It operates more than 150 affiliates in over 45 countries worldwide, as well as manages a staff of approximately 30,000 employees. Boehringer Ingelheim Corporation, since its founding in 1885, is a family-owned company. It additionally focuses on the development, manufacturing and marketing of novel therapeutic products for human and animals.